The rot eating at China’s war machine

Arms revenues for eight major Chinese state-owned defense firms fell 10% to USD 88.3 billion in 2024, with China North Industries (NORINCO) down 31%, China Aerospace Science and Technology Corporation (CASC) down 16% and Aviation Industry Corporation of China (AVIC) down 1.3% after high-profile anti-graft probes triggered postponements, cancellations and reviews of major contracts. The revenue hits and program delays—affecting satellites, launch vehicles, missiles and aircraft deliveries—are attributed to systemic procurement corruption and Xi Jinping’s centralizing purges, which analysts say have prioritized political loyalty over competence and could materially weaken China’s modernization and contingency capabilities, posing downside risk to defense suppliers and regional strategic stability.

Analysis

Market structure: The SIPRI data (NORINCO -31%, CASC -16%, AVIC -1.3%) signals a meaningful demand shock in Chinese state defense procurement—direct losers are Chinese SOEs and upstream suppliers; winners are Western defense primes (LMT, RTX, NOC) and allied niche suppliers who can pick up export or aftermarket work. Expect short-term pricing power for non‑Chinese suppliers in contested export markets and a rotation of R&D spend toward dual‑use semiconductors and satellite subsystems.

Risk assessment: Tail risks cut both ways: (a) a fiscal/state rescue (nationalization or directed financing) could reflate SOE bonds and equities within 3–12 months; (b) deeper institutional rot could permanently reduce PLA readiness, prompting accelerated Western and regional defense budgets (6–24 months). Watch catalysts: new purge announcements, China's sovereign 5y CDS widening >30 bps, or a DoD update on China capability — any of which can swing markets rapidly.

Trade implications: Near term (days–weeks) favor risk‑off: buy USD/CNH exposure (3‑month call spread targeting CNH +3–5%) and hedges in GLD (1–2% portfolio) while initiating measured longs in US defense primes (2–3% positions) for 6–18 month re-rating; short Chinese defense/industrial exposure via FXI puts (3–6 month, ~10% OTM) anticipating 10–25% downside if contract pipelines remain stalled. Use option spreads to cap cost and set stop-losses (equities −8% / FXI rise +8%).

Contrarian angles: Consensus underestimates Beijing’s capacity to reallocate capital—state support or consolidation could benefit private Chinese dual‑use contractors (SMIC as a strategic substitute) and SEMI‑equipment names (ASML, KLAC) long term (12–36 months). Conversely, markets may be overpricing permanent capability collapse; monitor policy signals over next 30–90 days before scaling positions.

Key Decisions for Investors

• Establish a 2–3% portfolio long in Lockheed Martin (LMT) and split equally into LMT and Raytheon (RTX) via buy-and-hold for 6–18 months; target +12% upside, stop-loss at −8% to capture potential re-rating from displaced Chinese procurement.
• Initiate a 1.5–2% notional long USD/CNH position via a 3‑month call spread sized to profit on a 3–5% CNH depreciation; unwind if CNH strengthens >2% from entry or if Chinese sovereign 5y CDS tightens by >20 bps.
• Short China large-cap exposure: buy 3–6 month FXI puts ~10% OTM (size 1–2% portfolio) or short FXI equivalent; take profits if FXI falls 12% or cut losses if it rallies 8%—add further if Chinese SOE bond spreads widen >30 bps.
• Allocate 1–2% to gold (GLD) or long-dated VIX call spreads as a tail-hedge for geopolitical/contagion risk; rebalance if defense equities outperform by >15% or if a major anti-corruption/safety net policy is announced within 30 days.